Allogeneic Transplantation Using Mini-Conditioning for Treatment of Stage IV Breast Cancer
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Peripheral stem cell transplantation may be able to replace immune
cells that were destroyed by chemotherapy. Donor lymphocytes may attack and destroy cancer
cells.
PURPOSE: This phase II trial is studying the effectiveness of combination chemotherapy,
peripheral stem cell transplantation, and donor lymphocyte infusion in treating women with
stage IV breast cancer.